To overcome the short duration of therapeutic protein expression associated with mRNA, Sail Biomedicine has developed novel endless RNA constructs. Michael Lam, Ph.D., discusses its delivery mechanisms and an outlook for future applications.
- Biomaterials In Ophthalmology Are Reshaping Ocular Drug Delivery
- Why Improving Drug Delivery Remains A Major Opportunity In Oncology
- Crossing The Brain's Barrier: Recent Advances And What Lies Ahead
- Navigating Combination Products: Device Complexity And Software Integration
- Improving Execution Of Biological Evaluation Of Drug Delivery Devices
- DDW 2026 Signalled The Next Era Of Competitive Landscape In IBD
- From Exosomes To Nanodrugs: Advancing Therapeutic Delivery For CNS Repair
- Risk Is the Spine: What The First 100 QMSR Inspections Reveal
ON-DEMAND WEBINARS
Developing new delivery routes is essential for creating more effective treatments. Nanoforming enables new routes to simplify dosing, enhance patient comfort, and reduce healthcare costs.
If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.
Explore the challenges related to packaging of cell and gene therapy products and proven solutions to enable speed to market and compatibility, performance of packaging materials.
Explore primary packaging developed following well-established ICH principles for sustainable compliance and vial container closure systems for product development and commercial manufacturing needs.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![drug-delivery-GettyImages-1156884561]( "The Gateway Delivery To The Brain")
The Gateway Delivery To The BrainNose‑to‑brain delivery enables targeted neurological treatment by using direct neural pathways to boost precision and limit systemic exposure, with new formulations and devices driving rapid progress.
-
![Autoinjector-Insulin-Pen-Delivery-Device-GettyImages- 1086688132]( "Is The Autoinjector Dead? The Future Of Patient-Centered Drug Delivery")
Is The Autoinjector Dead? The Future Of Patient-Centered Drug DeliveryAutoinjectors revolutionized drug delivery, but innovation is shifting toward oral, wearable, and alternative platforms. Future focus emphasizes patient experience, sustainability, and broader drug delivery toolkits beyond the autoinjector.
-
![06 West]( "Your Approach To USP <382> For Your Drug Product Packaging")
Your Approach To USP <382> For Your Drug Product PackagingThe USP requirements for elastomeric components of container closure systems used for parenteral products are changing. Explore the implications for vial, syringe, and cartridge container closure systems.
-
![GettyImages-1388184871-quality-compliance-approval]( "From Regulators To PUPSIT: Notes On Annex 1 Revision Implementation")
From Regulators To PUPSIT: Notes On Annex 1 Revision ImplementationKevin Smyth, a biochemical engineer with 30 years of experience in the pharmaceutical industry, offers insights and expertise in working with firms to understand what regulators seek to meet new standards.
-
![iStock-842481112-child-medicine-tablet-capsule]( "Pediatric Dosage Form Development: Program Design And Formulation Development")
Pediatric Dosage Form Development: Program Design And Formulation DevelopmentExplore key considerations to successfully bridge from initial concept of pediatric program design and formulation development strategies into later stages of development and through to commercialization.
-
![West1]( "Early Decisions To De-Risk The Transition To Combination Products")
Early Decisions To De-Risk The Transition To Combination ProductsThe injectable product development landscape is changing, and the pressure to accelerate timelines remains constant. What can you do to overcome all the uncertainty and risk?
-
![thinkstock_pharma_manufacturing_450x3001]( "Parenteral Packaging And Delivery Systems: Container Closure Integrity")
Parenteral Packaging And Delivery Systems: Container Closure IntegrityReview the chapter, USP <1207> Package Integrity Evaluation – Sterile Products, which covers CCI and different methods of selection and validation.
-
![GettyImages-1309471798 respiratory]( "Outlining The Trends And Challenges In The Inhaled Drug Delivery Market")
Outlining The Trends And Challenges In The Inhaled Drug Delivery MarketExplore the latest trends and solutions in inhaled drug delivery, with a focus on overcoming dry powder formulation challenges to advance next-generation therapeutics.
-
![GettyImages-525440891-lab-research-development]( "Making The Right Choice For Multiparticulate Modified Release Dosage Forms")
Making The Right Choice For Multiparticulate Modified Release Dosage FormsWurster processing is a versatile pharmaceutical development and manufacturing technique for multiparticulates in modified release dosage forms. Understand if it's the right method for your modified-release project.
-
![GettyImages-1328085510-patient-child-doctor-pediatric]( "Combining Patient Centricity And Commercial Viability In Pediatric Product Development")
Combining Patient Centricity And Commercial Viability In Pediatric Product DevelopmentMedication acceptance and adherence are critical concerns in pediatric populations due to these patients’ rapid anatomical and physiological development.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
Fran offers keen industry and technical insights exclusively on Drug Delivery Leader.
DELIVERED BY DEGRAZIO
-
![Delivered _by _DeGrazio_Logo_Color_2]( "Procuring Packaging And Delivery Systems: Single Versus Dual Sourcing")
Procuring Packaging And Delivery Systems: Single Versus Dual SourcingIn this article, Fran DeGrazio examines the trend toward dual sourcing of products, components, and materials for drug delivery packaging and systems. She outlines the key differences between single and dual sourcing and makes recommendations about using one versus the other while mitigating supply chain and product quality risk.
FREE EBOOK: COMBINATION PRODUCTS
Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.
